2022
Antiplatelet regimens following carotid artery revascularization
Lee M, Ahmed ZV, Huang J, Brice A, Arham A, Castro-Dominguez Y, Aboian E, Nagpal S, Smolderen KG, Mena-Hurtado C. Antiplatelet regimens following carotid artery revascularization. American Heart Journal 2022, 253: 48-52. PMID: 35863439, DOI: 10.1016/j.ahj.2022.07.004.Peer-Reviewed Original ResearchConceptsDual antiplatelet therapySingle antiplatelet therapyCarotid artery stentingCarotid endarterectomyAntiplatelet therapyReal-world clinical practiceCarotid artery revascularizationLow adherence ratesArtery revascularizationArtery stentingAdherence ratesClinical practicePatientsTherapyEngland dataHigh percentageRevascularizationAntiplateletEndarterectomyStentingPROGNOSTIC VALIDITY OF FRAILTY ASSESSMENT TOOLS IN PREDICTION OF MORTALITY AND MAJOR AMPUTATION IN PATIENTS UNDERGOING REVASCULARIZATION FOR LOWER EXTREMITY ARTERIAL DISEASE
Nikooie R, Smolderen K, Al-Damluji M, Meng C, Dai F, Nanna M, Sumpio B, Henke P, Mena-Hurtado C. PROGNOSTIC VALIDITY OF FRAILTY ASSESSMENT TOOLS IN PREDICTION OF MORTALITY AND MAJOR AMPUTATION IN PATIENTS UNDERGOING REVASCULARIZATION FOR LOWER EXTREMITY ARTERIAL DISEASE. Journal Of The American College Of Cardiology 2022, 79: 1779. DOI: 10.1016/s0735-1097(22)02770-x.Peer-Reviewed Original Research
2021
Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a real-world cohort: The CLEVER trial versus the PORTRAIT registry
Scierka LE, Jelani QU, Smolderen KG, Gosch K, Spertus JA, Mena-Hurtado C, Jones P, Dreyer RP. Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a real-world cohort: The CLEVER trial versus the PORTRAIT registry. Contemporary Clinical Trials 2021, 112: 106624. PMID: 34793986, DOI: 10.1016/j.cct.2021.106624.Peer-Reviewed Original ResearchConceptsOptimal medical therapyPeripheral artery diseasePatient characteristicsBaseline patient characteristicsPAD cohortPAD populationPORTRAIT registryExercise therapyPAD patientsPAD symptomsArtery diseaseFinal cohortMedical therapyProspective studyBurdensome diseaseControl trialHealth statusPatientsTherapyCohortCLEVER studyDiseaseMulticenterRevascularizationRCTsGUIDELINE CONCORDANT ANTIPLATELET REGIMENS IN PATIENTS WHO UNDERWENT CAROTID ARTERY REVASCULARIZATION: INSIGHTS FROM THE VASCULAR QUALITY INITIATIVE REGISTRY
Ahmed Z, Lee M, Huang J, Brice A, Arham A, Dominguez Y, Aboian E, Nagpal S, Smolderen K, Hurtado C. GUIDELINE CONCORDANT ANTIPLATELET REGIMENS IN PATIENTS WHO UNDERWENT CAROTID ARTERY REVASCULARIZATION: INSIGHTS FROM THE VASCULAR QUALITY INITIATIVE REGISTRY. Journal Of The American College Of Cardiology 2021, 77: 1078. DOI: 10.1016/s0735-1097(21)02437-2.Peer-Reviewed Original Research
2019
ONE-YEAR MAJOR ADVERSE LIMB EVENTS AND PLANNED REVASCULARIZATIONS FOLLOWING INVASIVE VERSUS OPTIMAL MEDICAL THERAPY FOR NEW OR WORSENING OF CLAUDICATION SYMPTOMS: INSIGHTS FROM THE PORTRAIT REGISTRY
Smolderen K, Safley D, Jones P, Patel M, Jones S, Shishehbor M, Aronow H, Labrosciano C, Fuss C, Scott K, Stone N, Spertus J. ONE-YEAR MAJOR ADVERSE LIMB EVENTS AND PLANNED REVASCULARIZATIONS FOLLOWING INVASIVE VERSUS OPTIMAL MEDICAL THERAPY FOR NEW OR WORSENING OF CLAUDICATION SYMPTOMS: INSIGHTS FROM THE PORTRAIT REGISTRY. Journal Of The American College Of Cardiology 2019, 73: 2115. DOI: 10.1016/s0735-1097(19)32721-4.Peer-Reviewed Original Research
2016
Clinical Relevance of Rehospitalizations for Unstable Angina and Unplanned Revascularization Following Acute Myocardial Infarction
Shore S, Smolderen KG, Spertus JA, Kennedy KF, Jones PG, Zhao Z, Wang TY, Arnold SV. Clinical Relevance of Rehospitalizations for Unstable Angina and Unplanned Revascularization Following Acute Myocardial Infarction. Journal Of The American Heart Association 2016, 5: e003129. PMID: 27543798, PMCID: PMC5015270, DOI: 10.1161/jaha.115.003129.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionUnplanned revascularizationUnstable anginaMyocardial infarctionSubsequent rehospitalizationClinical relevanceAcute Myocardial Infarction RegistryProportional hazard Cox regressionUnplanned coronary revascularizationComposite end pointMyocardial Infarction RegistryRehospitalization groupCause mortalityCoronary revascularizationRevascularization groupRehospitalization ratesPropensity matchingCox regressionMean ageClinical trialsRehospitalizationRevascularizationMortality riskHigh riskPatients